70
Participants
Start Date
November 1, 2017
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Intravenous immunoglobulin
This is a blood product containing antibodies from thousands of healthy donors.
Placebo
This is the control, or sham, treatment
Rituximab
Rituximab is a type of biological therapy. It removes B-cells and helps to reduce the inflammation
RECRUITING
Cambridge University Hospitals NH Foundation Trust, Cambridge
RECRUITING
Royal Devon and Exeter NHS Foundation Trust, Exeter
RECRUITING
NHS Greater Glasgow and Clyde, Glasgow
RECRUITING
The Walton Centre NHS Foundation Trust, Liverpool
RECRUITING
King's College Hospital NHS Foundation Trust, London
RECRUITING
Salford Royal NHS Foundation Trust, Manchester
RECRUITING
Nottingham University Hospitals NHS Trust, Nottingham
RECRUITING
Oxford University Hospitals NHS Foundation Trust, Oxford
RECRUITING
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
RECRUITING
University College London Hospitals Nhs Foundation Trust, London
University of Oxford
OTHER
University of Cambridge
OTHER